Ten-Year Survival of Patients with Locally Advanced, Stage IB–IIB Cervical Cancer after Neoadjuvant Chemotherapy and Radical Hysterectomy-Reference-Cited by-同舟云学术

Ten-Year Survival of Patients with Locally Advanced, Stage IB–IIB Cervical Cancer after Neoadjuvant Chemotherapy and Radical Hysterectomy

Published:2001-07 Issue:1 Volume:82 Page:88-93
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Hwang Youn Yeoung,Moon Hyung,Cho Sam Hyun,Kim Kyung Tai,Moon Young Jin,Kim Seung Ryong,Kim Doo Sang

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference16 articles.

1. Cervical carcinoma: a drug responsive tumor—experience with combined cisplatin, vinblastine, bleomycin;Friedlander;Gynecol Oncol,1983

2. Preoperative adjuvant chemotherapy in the treatment of cervical cancer stage Ib, IIa, and IIb with bulky tumor;Kim;Gynecol Oncol,1988

3. A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma;Weiner;Obstet Gynecol,1988

4. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical carcinoma: a pilot study;Panici;Obstet Gynecol,1988

5. Two-year survival: preoperative adjuvant chemotherapy in the treatment of cervical cancer stages Ib and II with bulky tumor;Kim;Gynecol Oncol,1989

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunohistochemical markers Ki67 and P16 help predict prognosis in locally advanced cervical cancer;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-03

2. Expression and clinical significance of Ki-67 and P16 after neoadjuvant chemotherapy for locally advanced cervical cancer;2023-03-14

3. Chemotherapy and immune check point inhibitors in the management of cervical cancer;Current Problems in Cancer;2022-12

4. Laparoscopic Radical Hysterectomy Combined with Neoadjuvant Chemotherapy for Cervical Cancer Patients Effectively Improves Immune Function;Disease Markers;2022-09-14

5. Clinical outcome of FIGO 2018 stage IB3/IIA2 cervical cancer treated by neoadjuvant chemotherapy followed by radical surgery due to lack of radiotherapy equipment: A retrospective comparison with concurrent chemoradiotherapy;PLOS ONE;2022-03-24